MYNZ
Price
$2.06
Change
+$0.17 (+8.99%)
Updated
Jul 21, 04:16 PM (EDT)
Capitalization
20.77M
44 days until earnings call
STXS
Price
$2.23
Change
-$0.09 (-3.88%)
Updated
Jul 21, 04:59 PM (EDT)
Capitalization
214.36M
17 days until earnings call
Interact to see
Advertisement

MYNZ vs STXS

Header iconMYNZ vs STXS Comparison
Open Charts MYNZ vs STXSBanner chart's image
Mainz Biomed
Price$2.06
Change+$0.17 (+8.99%)
Volume$1K
Capitalization20.77M
Stereotaxis
Price$2.23
Change-$0.09 (-3.88%)
Volume$1.29K
Capitalization214.36M
MYNZ vs STXS Comparison Chart in %
Loading...
MYNZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MYNZ vs. STXS commentary
Jul 22, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MYNZ is a Hold and STXS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 22, 2025
Stock price -- (MYNZ: $1.89 vs. STXS: $2.32)
Brand notoriety: MYNZ and STXS are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: MYNZ: 80% vs. STXS: 149%
Market capitalization -- MYNZ: $20.77M vs. STXS: $214.36M
MYNZ [@Medical Specialties] is valued at $20.77M. STXS’s [@Medical Specialties] market capitalization is $214.36M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.74B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MYNZ’s FA Score shows that 1 FA rating(s) are green whileSTXS’s FA Score has 0 green FA rating(s).

  • MYNZ’s FA Score: 1 green, 4 red.
  • STXS’s FA Score: 0 green, 5 red.
According to our system of comparison, both MYNZ and STXS are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MYNZ’s TA Score shows that 3 TA indicator(s) are bullish while STXS’s TA Score has 6 bullish TA indicator(s).

  • MYNZ’s TA Score: 3 bullish, 6 bearish.
  • STXS’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, STXS is a better buy in the short-term than MYNZ.

Price Growth

MYNZ (@Medical Specialties) experienced а -1.56% price change this week, while STXS (@Medical Specialties) price change was +3.11% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.54%. For the same industry, the average monthly price growth was +3.32%, and the average quarterly price growth was -2.57%.

Reported Earning Dates

MYNZ is expected to report earnings on Sep 03, 2025.

STXS is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Medical Specialties (+0.54% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
STXS($214M) has a higher market cap than MYNZ($20.8M). STXS YTD gains are higher at: 1.754 vs. MYNZ (-56.250). STXS has higher annual earnings (EBITDA): -21.24M vs. MYNZ (-27.15M). STXS has more cash in the bank: 19.8M vs. MYNZ (9.32M). STXS has less debt than MYNZ: STXS (5.49M) vs MYNZ (10.2M). STXS has higher revenues than MYNZ: STXS (26.8M) vs MYNZ (874K).
MYNZSTXSMYNZ / STXS
Capitalization20.8M214M10%
EBITDA-27.15M-21.24M128%
Gain YTD-56.2501.754-3,206%
P/E RatioN/AN/A-
Revenue874K26.8M3%
Total Cash9.32M19.8M47%
Total Debt10.2M5.49M186%
FUNDAMENTALS RATINGS
STXS: Fundamental Ratings
STXS
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
92
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
47
P/E GROWTH RATING
1..100
61
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
MYNZSTXS
RSI
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 7 days ago
82%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
88%
Momentum
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 4 days ago
88%
MACD
ODDS (%)
Bullish Trend 4 days ago
85%
Bullish Trend 4 days ago
77%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
73%
Bullish Trend 4 days ago
82%
Advances
ODDS (%)
Bullish Trend 4 days ago
77%
Bullish Trend 8 days ago
77%
Declines
ODDS (%)
Bearish Trend 8 days ago
90%
Bearish Trend 4 days ago
81%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
MYNZ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MQMIF0.060.02
+71.43%
METALQUEST MINING INC.
SCPPF0.320.02
+5.75%
S4 Capital PLC
EVGGF89.173.96
+4.65%
Evolution AB
RIOFF1.130.02
+1.53%
RIO2 Limited
RPHCF14.72N/A
N/A
Rohto Pharmaceutical Co.

MYNZ and

Correlation & Price change

A.I.dvisor indicates that over the last year, MYNZ has been loosely correlated with ACRS. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if MYNZ jumps, then ACRS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MYNZ
1D Price
Change %
MYNZ100%
+2.72%
ACRS - MYNZ
40%
Loosely correlated
+1.26%
STXS - MYNZ
26%
Poorly correlated
-2.52%
SINT - MYNZ
23%
Poorly correlated
N/A
BLFS - MYNZ
23%
Poorly correlated
-2.75%
CVRX - MYNZ
22%
Poorly correlated
-4.19%
More